AAV2-GAD gene therapy for advanced Parkinson's disease: A double-blind, sham-surgery controlled, randomised trial

Peter A. LeWitt, Ali R. Rezai, Maureen A. Leehey, Steven G. Ojemann, Alice W. Flaherty, Emad N. Eskandar, Sandra K. Kostyk, Karen Thomas, Atom Sarkar, Mustafa S. Siddiqui, Stephen B. Tatter, Jason M. Schwalb, Kathleen L. Poston, Jaimie M. Henderson, Roger M. Kurlan, Irene H. Richard, Lori Van Meter, Christine V. Sapan, Matthew J. During, Michael G. KaplittAndrew Feigin

Research output: Contribution to journalArticlepeer-review

441 Scopus citations

Fingerprint

Dive into the research topics of 'AAV2-GAD gene therapy for advanced Parkinson's disease: A double-blind, sham-surgery controlled, randomised trial'. Together they form a unique fingerprint.

Medicine & Life Sciences